文献速递创伤与烧伤心脑血管急症重症综合管理与镇静镇痛

创伤性脑损伤后生成的微囊泡通过二磷酸腺苷受体诱导血小板功能障碍

Microvesicles generated following traumatic brain injury induce platelet dysfunction via adenosine diphosphate receptor.
PubMed 文献 · J Trauma Acute Care Surg · 2019-01-01
一句话结论小鼠中度脑创伤后10分钟血浆及微囊泡通过P2Y12受体抑制ADP诱导的血小板聚集,P2Y12抑制剂R-138727可预防此功能障碍。

该研究采用小鼠重量坠落法中度创伤性脑损伤模型,于伤后10分钟采集全血、血浆、微囊泡及微囊泡贫乏血浆,分别与未受伤小鼠全血混合,用Multiplate阻抗血小板聚集仪检测ADP诱导的血小板聚集。结果显示伤后全血ADP诱导血小板聚集较假手术组减弱;伤后血浆和微囊泡可使正常供血ADP诱导血小板聚集减弱,而微囊泡贫乏血浆无此作用。用P2Y12受体抑制剂R-138727预处理伤后血浆或微囊泡,可预防或改善ADP诱导的血小板聚集障碍。作者认为伤后微囊泡内ADP P2Y12受体可能部分解释临床所见的伤后血小板功能障碍。

要点

  • 小鼠中度脑创伤后10分钟全血ADP诱导的血小板聚集较假手术组减弱。
  • 伤后血浆和微囊泡与正常全血混合可减弱ADP诱导血小板聚集,微囊泡贫乏血浆无此作用。
  • P2Y12受体抑制剂R-138727预处理伤后血浆可预防ADP诱导的血小板聚集障碍。
  • R-138727处理伤后微囊泡可改善ADP诱导血小板聚集,与未处理伤后微囊泡相比结果相似。
  • 作者认为伤后微囊泡内的ADP P2Y12受体可能部分解释临床所见的伤后血小板功能障碍。

适用人群与场景

  • 雄性C57BL6小鼠,采用重量坠落法建立中度创伤性脑损伤模型,伤后10分钟采血。

研究设计与关键结果

  • 研究类型为小鼠实验研究,样本量原文未报告;伤后10分钟全血ADP诱导血小板聚集较假手术组减弱。
  • 伤后血浆和微囊泡与正常供血混合后ADP诱导血小板聚集较假手术血浆和假手术微囊泡减弱;伤后微囊泡贫乏血浆加入正常血后ADP诱导血小板聚集无变化。
  • 伤后血浆经R-138727预处理可预防观察到的ADP血小板聚集功能障碍;伤后微囊泡经R-138727处理改善ADP诱导血小板聚集,与未处理伤后微囊泡相比结果相似。

证据类型、等级与局限

  • 证据类型:动物实验(小鼠中度创伤性脑损伤模型);证据等级:Level III。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为临床观察到的伤后血小板功能障碍可能部分由伤后微囊泡内ADP P2Y12受体解释。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Traumatic brain injury (TBI) can result in an acute coagulopathy including platelet dysfunction that can contribute to ongoing intracranial hemorrhage. Previous studies have shown adenosine diphosphate (ADP)-induced platelet aggregation to be reduced after TBI. In addition, circulating microvesicles (MVs) are increased following TBI and have been shown to play a role in post-TBI coagulopathy and platelet function. We hypothesized that post-TBI MVs would affect platelet aggregation in a murine head injury model.

METHODS: Moderate TBI was performed using a weight-drop method in male C57BL6 mice. Whole blood, plasma, MVs, and MV-poor plasma were isolated from blood collected 10 minutes following TBI and were mixed separately with whole blood from uninjured mice. Platelet aggregation was measured with Multiplate impedance platelet aggregometry in response to ADP. The ADP P2Y12 receptor inhibitor, R-138727, was incubated with plasma and MVs from TBI mice, and platelet inhibition was again measured.

RESULTS: Whole blood taken from 10-minute post-TBI mice demonstrated diminished ADP-induced platelet aggregation compared with sham mice. When mixed with normal donor blood, post-TBI plasma and MVs induced diminished ADP-induced platelet aggregation compared with sham plasma and sham MVs. By contrast, the addition of post-TBI MV-poor plasma to normal blood did not change ADP-induced platelet aggregation. The observed dysfunction in post-TBI ADP platelet aggregation was prevented by the pretreatment of post-TBI plasma with R-138727. Treatment of post-TBI MVs with R-138727 resulted in similar findings of improved ADP-induced platelet aggregation compared with nontreated post-TBI MVs.

CONCLUSION: Adenosine diphosphate-induced platelet aggregation is inhibited acutely following TBI in a murine model. This platelet inhibition is reproduced in normal blood by the introduction of post-TBI plasma and MVs. Furthermore, observed platelet dysfunction is prevented when post-TBI plasma and MVs are treated with an inhibitor of the P2Y12 ADP receptor. Clinically observed post-TBI platelet dysfunction may therefore be partially explained by the presence of the ADP P2Y12 receptor within post-TBI MVs.

LEVEL OF EVIDENCE: Level III.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Martin GE, Pugh AM, Moran R, et al. Microvesicles generated following traumatic brain injury induce platelet dysfunction via adenosine diphosphate receptor. J Trauma Acute Care Surg. 2019. PMID: 30614923. doi:10.1097/TA.0000000000002171

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。